Search filters

List of works by Hans W Nijman

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

scientific article published on 12 February 2018

CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer.

scientific article

Deep immune profiling of ovarian tumors identifies minimal MHC-I expression after neoadjuvant chemotherapy as negatively associated with T-cell-dependent outcome

scientific article published on 13 May 2020

Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer-Combined Analysis of the PORTEC Cohorts.

scientific article

Long-Term Impact of Endometrial Cancer Diagnosis and Treatment on Health-Related Quality of Life and Cancer Survivorship: Results From the Randomized PORTEC-2 Trial

scientific article published on 18 August 2015

Potent therapeutic efficacy of an alphavirus replicon DNA vaccine expressing human papilloma virus E6 and E7 antigens

scientific article published on 26 July 2018

Prognostic image-based quantification of CD8CD103 T cell subsets in high-grade serous ovarian cancer patients

scientific article published on 06 June 2021

Short-term surgical complications after radical hysterectomy-A nationwide cohort study

scientific article published on 18 January 2020

Strong vaccine responses during chemotherapy are associated with prolonged cancer survival

scientific article published on 01 March 2020

Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial

scientific article published on 7 July 2016

Paulina is supported by:

About Paulina

Help